These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 4355974)

  • 41. [Problems posed by the immunological properties common to Burkitt's lymphoma and cancer. Means of resolving them].
    De-Thé G
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):767-88. PubMed ID: 4340546
    [No Abstract]   [Full Text] [Related]  

  • 42. Anti-Epstein Barr virus antibody in nasopharyngeal carcinoma.
    Hsu MM; Chiou JF; McCabe BF
    Ann Otol Rhinol Laryngol; 1974; 83(1):19-25. PubMed ID: 4359674
    [No Abstract]   [Full Text] [Related]  

  • 43. Antibody to Epstein-Barr virus in American patients with carcinoma of the nasopharynx.
    Goldman JM; Goodman ML; Miller D
    JAMA; 1971 Jun; 216(10):1618-22. PubMed ID: 4325362
    [No Abstract]   [Full Text] [Related]  

  • 44. Antibodies against tumours.
    Br Med J; 1971 Nov; 4(5786):505-6. PubMed ID: 4331480
    [No Abstract]   [Full Text] [Related]  

  • 45. [EB virus-associated tumors-opportunistic B cell lymphoma, Burkitt's lymphoma, nasopharyngeal carcinoma].
    Mizuno F
    Nihon Rinsho; 1989 Feb; 47(2):481-6. PubMed ID: 2542671
    [No Abstract]   [Full Text] [Related]  

  • 46. Antibodies in human sera to soluble and viral antigens found in Burkitt lymphoma and other lymphoblastoid cell lines.
    Vonka V; Benyesh-Melnick M; McCombs RM
    J Natl Cancer Inst; 1970 Apr; 44(4):865-72. PubMed ID: 11515054
    [No Abstract]   [Full Text] [Related]  

  • 47. Seroepidemiology of Epstein-Barr virus infections in a developing country.
    Hossain A
    J Trop Pediatr; 1987 Oct; 33(5):257-60. PubMed ID: 2828648
    [No Abstract]   [Full Text] [Related]  

  • 48. [Anti-complement immunoperoxidase technique in the determination of EBNA antibody level in patients with nasopharyngeal carcinoma (author's transl)].
    Liu YX
    Zhonghua Zhong Liu Za Zhi; 1982 Feb; 4(1):20-2. PubMed ID: 6284464
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti-MA).
    de Schryver A; Klein G; Hewetson J; Rocchi G; Henle W; Henle G; Moss DJ; Pope JH
    Int J Cancer; 1974 Mar; 13(3):353-62. PubMed ID: 4362610
    [No Abstract]   [Full Text] [Related]  

  • 50. [Recent advances in the study of the etiology of nasopharyngeal cancer].
    Sawaki S
    Jibiinkoka; 1972 Mar; 44(3):165-77. PubMed ID: 4552662
    [No Abstract]   [Full Text] [Related]  

  • 51. Studies of the Epstein-Barr herpesvirus relationship with Hodgkin's disease and the use of virus immunological markers in differential diagnostics of nasopharyngeal carcinoma.
    Mazurenko NP; Gurtsevich VE; Stepina VN; Plakhov IV
    Arch Geschwulstforsch; 1983; 53(3):253-9. PubMed ID: 6311138
    [No Abstract]   [Full Text] [Related]  

  • 52. Blocking of direct membrane immunofluorescence in titration of membrane-reactive antibodies associated with Epstein-Barr virus.
    Gunvén P; Klein G
    J Natl Cancer Inst; 1971 Sep; 47(3):539-48. PubMed ID: 4333666
    [No Abstract]   [Full Text] [Related]  

  • 53. Difference in heat stability of antigens associated with Epstein-Barr virus, demonstrated by immunodiffusion.
    Demissie A
    J Natl Cancer Inst; 1973 Sep; 51(3):751-60. PubMed ID: 4355217
    [No Abstract]   [Full Text] [Related]  

  • 54. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
    Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surface antigens on lymphoblastoid cells derived from nasopharyngeal carcinoma.
    de Thé G; de Schryver A; Klein G
    Clin Exp Immunol; 1970 Aug; 7(2):161-71. PubMed ID: 4320167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].
    Mazeron MC
    Bull Cancer Radiother; 1996; 83(1):3-7. PubMed ID: 8679277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Detection of antibodies against Epstein's and Barr's virus in patients with carcinoma of the nasopharynx in the CSSR (author's transl)].
    Síbl O; Vonka V; Vlcková I; Závadová H
    Cas Lek Cesk; 1974 Oct; 113(42):1284-7. PubMed ID: 4370878
    [No Abstract]   [Full Text] [Related]  

  • 58. Cellular reactions against Burkitt Lymphoma cells. I. Colony inhibition with effector cells from patients with Burkitt's lymphoma.
    Hewetson JF; Golub SH; Klien G; Singh S
    Int J Cancer; 1972 Jul; 10(1):142-9. PubMed ID: 4350508
    [No Abstract]   [Full Text] [Related]  

  • 59. [A modified 131 I immuno-autoradiographic method for detection of serum EB virus VCA-IgA antibody in nasopharyngeal carcinoma].
    Shang M
    Zhonghua Zhong Liu Za Zhi; 1982 Nov; 4(4):262-4. PubMed ID: 6299669
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of local radiotherapy on the level of EBV-associated membrane-reactive antibodies in the sera of patients with certain malignant tumors.
    Einhorn N
    Cancer; 1972 Mar; 29(3):714-23. PubMed ID: 4551307
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.